BSF Enterprise and Ivy Farm Partner to Produce Cultivated Meat in China
Two UK firms, BSF Enterprise, owner of the UK clinical and cell ag company 3D Bio-Tissues (3DBT), and the cultivated meat company Ivy Farm Technologies, have partnered to fundraise, produce, and scale cultivated meat in China. BSF Enterprise (LSE: BSFA) (OTCQB: BSFAF) announced that the commercial agreement involves securing investment to help Ivy Farm enter the Chinese market and find key manufacturers to develop various cultivated meat products. Last year, BSF Enterprise …
BSF & CellRev Form New Venture ‘Cultivated Meat Technologies Limited’ to Mass-Produce Cultivated Meat
Two UK firms, BSF Enterprise, owner of the UK clinical and cell ag company 3D Bio-Tissues (3DBT), and bioprocessing company CellRev, will combine their resources and expertise to launch a new company focused on the mass production of cultivated meat. BSF Enterprise (LSE: BSFA), (OTCQB: BSFAF), announced the exclusive joint venture, revealing they had already entered a Terms Sheet and expect to form the biotech in the coming months. The news follows …
Biotech Firms Awarded €1.2M for Creating Animal-Free Cell Culture Media to Make Cultivated Meat a “Commercial Reality”
Commercializing cell-based products such as cultivated meat remains challenging due to the substantial costs and ethical implications of fetal bovine serum. To find solutions, EIT Food, the world’s largest and most dynamic food innovation community, and the Good Food Institute (GFI) Europe launched the Cultivated Meat Innovation Challenge to develop a more affordable and efficient animal-free cell culture media. The winners, UK biotech company 3D Bio-Tissues and Israeli biotech startup BioBetter have …
3D Bio-Tissues Opens Office in Hong Kong to Commercialise its Flagship Cell Media in China
UK-based clinical and cell ag company 3D Bio-Tissues (3DBT) has recently expanded internationally with a new office in Hong Kong to introduce its flagship cell-boosting media supplement, City-Mix, to the Chinese cultivated meat market. 3DBT will also target the Chinese biotech industry, especially gene therapy, stem cells, regenerative medicine, Life Sciences companies, and academia. The company already started hiring R&D experts and sales and marketing specialists to develop a go-to-market strategy, build distribution networks, …